360 High-Risk Vulnerability Immunization Tool V2.0 vs OPSWAT OESIS Framework: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

OPSWAT OESIS Framework: Cross-platform SDK for integrating endpoint security capabilities into products. built by OPSWAT. Core capabilities include Device posture assessment for 5,000+ applications, Automated patch detection and remediation, Vulnerability assessment covering 47,000+ CVEs and 100,000+ vulnerability instances..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. OPSWAT OESIS Framework differentiates with Device posture assessment for 5,000+ applications, Automated patch detection and remediation, Vulnerability assessment covering 47,000+ CVEs and 100,000+ vulnerability instances.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). OPSWAT OESIS Framework is developed by OPSWAT. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.

360 High-Risk Vulnerability Immunization Tool V2.0 and OPSWAT OESIS Framework serve similar Endpoint Protection Platform use cases: both cover Patch Management. Review the feature comparison above to determine which fits your requirements.